Factors that affect the efficacy of inhaled corticosteroids for infants and young children

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 6, 2010, Pages 1206-1211

  Amirav, Israel ^a   Newhouse, Michael T ^b   Minocchieri, Stefan ^c   Castro Rodriguez, Jose A ^d   Schüepp, Karen G ^e  

^a Rebecca Sieff Government Hospital   (Israel)

^b ST JOSEPH S HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

adherence; aerosol delivery devices; asthma; corticosteroids; infants; inhalers; nebulizers; Small particle aerosols

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID;

AEROSOL; ARTICLE; ASTHMA; BIOACCUMULATION; CHILD; CHILD BEHAVIOR; CRYING; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; EQUIPMENT DESIGN; FACE MASK; HIGH RISK POPULATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT; LUNG FUNCTION; METERED DOSE INHALER; MOLECULAR DYNAMICS; NEBULIZATION; PARTICLE SIZE; PRESCHOOL CHILD; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AEROSOLS; AGE FACTORS; ASTHMA; CHILD, PRESCHOOL; HUMANS; INFANT; PARTICLE SIZE; PATIENT COMPLIANCE;

EID: 77952745488     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.01.034     Document Type: Article

References (35)

1. Gold D.R., and Fuhlbrigge A.L. Inhaled corticosteroids for young children with wheezing. N Engl J Med 354 (2006) 2058-2060
2. Becquemin M.H., Swift D.L., Bouchikhi A., Roy M., and Teillac A. Particle deposition and resistance in the noses of adults and children. Eur Respir J 4 (1991) 694-702
3. Chua H.L., Collis G.G., Newbury A.M., Chan K., Bower G.D., Sly P.D., et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 7 (1994) 2185-2191
4. Cockcroft D.W., MacCormack D.W., Tarlo S.M., Hargreave F.E., and Pengelly L.D. Nasal airway inspiratory resistance. Am Rev Respir Dis 119 (1979) 921-926
5. Hislop A., Muir D.C.F., Jacobsen M., Simon G., and Lynne Reid L. Postnatal growth and function of the pre-acinar airways. Thorax 27 (1972) 265-274
6. Howarth P.H. Why particle size should affect clinical response to inhaled therapy. J Aerosol Med 14 suppl (2001) S27-S34
7. Mallol J., Rattray S., Walker G., Cook D., and Robertson C.F. Aerosol deposition in infants with cystic fibrosis. Pediatr Pulmonol 21 (1996) 276-281
8. Fok T.F., Monkman S., Dolovich M., Gray S., Coates G., Paes B., et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 21 (1996) 301-309
9. Amirav I., Balanov I., Gorenberg M., Luder A.S., Newhouse M.T., and Groshar D. Beta agonist aerosol distribution in RSV bronchiolitis in infants. J Nucl Med 43 (2002) 487-491
10. Wildhaber J.H., Dore N.D., Wilson J.M., Devadason S.G., and LeSouef P.N. Inhalation therapy in asthma; Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 135 (1999) 28-33
11. Tal A., Golan H., Grauer N., Aviram M., Albin D., and Quastral M.R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 128 (1996) 479-484
12. Murakami G., Igarashi T., Adachi Y., Matsuno M., Adachi Y., Sawai M., et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 64 (1990) 383-387
13. Iles R., Lister P., and Edmunds A.T. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 81 (1999) 163-165
14. Amirav I., Balanov I., Gorenberg M., Groshar D., and Luder A.S. Nebulizer hood compared to mask in wheezy infants: aerosol therapy without tears!. Arch Dis Child 88 (2003) 719-723
15. Schuepp K.G., Devadason S.G., Roller C., Minocchieri S., Moeller A., Hamacher J., et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 103 (2009) 1738-1745
16. Janssens H.M., Krijgsman A., Verbraak T.F., Hop W.C., de Jongste J.C., and Tiddens H.A. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med 17 (2004) 51-61
17. Amirav I., and Newhouse M.T. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 108 (2001) 389-394
18. Amirav I., and Newhouse M.T. Review of optimal characteristics of face-masks for valved-holding chambers (VHCs). Pediatr Pulmonol 43 (2008) 268-274
19. Everard M.L., Clark A.R., and Milner A.D. Drug delivery from jet nebulisers. Arch Dis Child 67 (1992) 586-591
20. Sangwan S., Gurses B.K., and Smaldone G.C. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 37 (2004) 447-452
21. Marguet C., Couderc L., Le Roux P., Jeannot E., Lefay V., and Mallet E. Inhalation treatment: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Pediatr Allergy Immunol 12 (2001) 224-230
22. Clark A.R., Chambers C.B., Muir D., Newhouse M.T., Paboojian S., and Schuler C. The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols. J Aerosol Med 20 (2007) 75-82
23. Everard M.L. Trying to deliver aerosols to upset children is a thankless task. Arch Dis Child 82 (2000) 428
24. Janssens H.M., De Jongste J.C., Hop W.C., and Tiddens H.A. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest 123 (2003) 2083-2088
25. Schüepp K.G., Jauernig J., Janssens H.M., Tiddens H.A., Straub D.A., Stangl R., et al. In vitro determination of the optimal particle size for nebulized aerosol delivery to infants. J Aerosol Med 18 (2005) 225-235
26. Schüepp K.G., Devadason S., Roller C., and Wildhaber J.H. A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children. Swiss Med Wkly 134 (2004) 198-200
27. Köhler E., Jilg G., Avenarius S., and Jorch G. Lung deposition after inhalation with various nebulisers in preterm infants. Arch Dis Child Fetal Neonatal Ed 93 (2008) F275-F279
28. Geller D.E., Eigen H., Fiel S.B., Clark A., Lamarre A.P., Johnson C.A., et al. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol 25 (1998) 83-87
29. Agertoft L., Laulund L.W., Harrison L.I., and Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatr Pulmonol 35 (2003) 192-199
30. Devadason S.G., Huang T., Walker S., Troedson R., and Le Souëf P.N. Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children. Eur Respir J 21 (2003) 1007-1011
31. Roller C.M., Zhang G., Troedson R.G., Leach C.L., Le Souëf P.N., and Devadason S.G. Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J 29 (2007) 299 e306
32. Ducharme F.M., Lemire C., Noya F.J., Davis G.M., Alos N., Leblond H., et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 360 (2009) 339-353
33. Pedersen S., Warner J., Wahn U., Staab D., Le Bourgeois M., Van Essen-Zandvliet E., et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics 109 (2002) e92
34. Skoner D.P., Maspero J., and Banerji D. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 121 (2008) e1-14
35. Lasserson T.J., Cates C.K., Jones A.B., Steele E.H., and White J. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children. Cochrane Database Syst Rev 2 (2006) CD005309